share_log

Assessing Vir Biotechnology: Insights From 5 Financial Analysts

Benzinga ·  Mar 15 10:00

Vir Biotechnology (NASDAQ:VIR) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings30200
Last 30D10000
1M Ago10100
2M Ago10100
3M Ago00000

Analysts have set 12-month price targets for Vir Biotechnology, revealing an average target of $64.8, a high estimate of $110.00, and a low estimate of $9.00. This current average has increased by 22.26% from the previous average price target of $53.00.

price target chart

Deciphering Analyst Ratings: An In-Depth Analysis

The standing of Vir Biotechnology among financial experts becomes clear with...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment